# Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

> **NCT06713434** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Fundación DEBRA Chile, Niños Piel de Cristal** · enrollment: 20 (estimated)

## Conditions studied

- Junctional Epidermolysis Bullosa
- Epidermolysis Bullosa (EB)
- Dystrophic Epidermolysis Bullosa
- Recessive Dystrophic Epidermolysis Bullosa

## Interventions

- **BIOLOGICAL:** ELK-003 (Standarized Amniotic Fluid Secretome Eye Drops)

## Key facts

- **NCT ID:** NCT06713434
- **Lead sponsor:** Fundación DEBRA Chile, Niños Piel de Cristal
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-07
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06713434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06713434, "Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06713434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*